Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The avidin–biotin interaction is a high-affinity, non-covalent binding system used to target tumor tissues. A biotinylated targeting molecule (e.g., antibody) is administered, followed by a clearing agent (avidin/streptavidin) and then a biotinylated drug or imaging agent. The high affinity and multivalency of the interaction allow for enhanced tumor localization and payload delivery. It is not a therapeutic target in itself, but instead is a drug delivery system.
Pretargeting: Biotinylated targeting agent localizes to tumor, followed by avidin/streptavidin clearance, and subsequent administration of biotinylated payload.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor-localized Tissue via Avidin–Biotin Interaction.